Systemic therapies for recurrent and/or metastatic salivary gland cancers.
about
Ardipusilloside I induces apoptosis by regulating Bcl-2 family proteins in human mucoepidermoid carcinoma Mc3 cells.Mutational landscape of lacrimal gland carcinomas and implications for treatmentNuclear Multidrug Resistance-Related Protein 1 Is Highly Associated with Better Prognosis of Human Mucoepidermoid Carcinoma through the Suppression of Cell Proliferation, Migration and Invasion.Targeting ERK1/2-bim signaling cascades by BH3-mimetic ABT-737 as an alternative therapeutic strategy for oral cancer.Prognostic and therapeutic potential of nuclear receptors in head and neck squamous cell carcinomas.Maslinic acid induces apoptosis in salivary gland adenoid cystic carcinoma cells by Ca2+-evoked p38 signaling pathway.Baicalin induces human mucoepidermoid carcinoma Mc3 cells apoptosis in vitro and in vivo.Phosphorylated epidermal growth factor receptor expression and KRAS mutation status in salivary gland carcinomas.Convallaria keiskei as a novel therapeutic alternative for salivary gland cancer treatment by targeting myeloid cell leukemia-1.Carcinoma of the salivary glands: guidelines and case report of sustained remission with docetaxel.Oncocytic carcinoma of the parotid gland.Metastatic HER-2-positive salivary gland carcinoma treated with trastuzumab and a taxane: a series of six patients.Silymarin and its active component silibinin act as novel therapeutic alternatives for salivary gland cancer by targeting the ERK1/2-Bim signaling cascade.Expression of miRNAs in adenoid cystic carcinomas of the breast and salivary glands.
P2860
Q35047698-E5900640-B026-461A-8166-1786178633CDQ35611040-949C8641-C7BB-403C-91A5-B10AF12FD0EAQ35909729-D8523CF7-CF27-42EF-A79B-B51A4C5DD1B0Q36546429-DA82C3D9-DD23-49EA-809C-13A3BC91DBE2Q37606299-8792DD75-6400-40E3-962F-BBBB2DCA49D6Q39600560-55BCD123-701B-4A2A-9C96-599A4FDCC0D3Q39732001-E4FC3327-0D45-4A99-94EF-5BABD905E130Q40657619-71794154-FFB5-4C2B-B75D-29E96D224FEDQ41011587-DEFB11C2-6056-485B-84C3-E14A32F3C426Q43874354-DFC86E43-E803-4EFA-B3D8-1421E884BD78Q46413944-490B737E-2A8E-4D41-BB2A-E3750233604AQ51709905-D759CAA5-3B13-4ED7-B768-BEA498775C3EQ52098928-49FCC12A-8554-45B6-B2BF-5912BCAB80A3Q53378204-360E1ADC-CC66-4395-9F45-A56DCF48995A
P2860
Systemic therapies for recurrent and/or metastatic salivary gland cancers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Systemic therapies for recurrent and/or metastatic salivary gland cancers.
@en
Systemic therapies for recurrent and/or metastatic salivary gland cancers.
@nl
type
label
Systemic therapies for recurrent and/or metastatic salivary gland cancers.
@en
Systemic therapies for recurrent and/or metastatic salivary gland cancers.
@nl
prefLabel
Systemic therapies for recurrent and/or metastatic salivary gland cancers.
@en
Systemic therapies for recurrent and/or metastatic salivary gland cancers.
@nl
P2093
P2860
P356
P1476
Systemic therapies for recurrent and/or metastatic salivary gland cancers.
@en
P2093
Alessia Caldara
Claudio Graiff
Emanuela Vattemi
Marta Mandarà
Rebecca Pedersini
Teodoro Sava
P2860
P304
P356
10.1586/14737140.8.3.393
P577
2008-03-01T00:00:00Z